Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|September 1, 1997
Supplements and Featured Publications
- Cost-Effective Treatment of Rhinitis: A Managed Care Perspective
- Volume 3
- Issue 9 Suppl
Goals and Objectives
Advertisement
Articles in this issue
almost 29 years ago
The Health and Economic Impact of Rhinitisalmost 29 years ago
Assessing Outcomes Parametersalmost 29 years ago
Issues in Diagnosing and Therapyalmost 29 years ago
Selected Abstractsalmost 29 years ago
CME Quizalmost 29 years ago
Bibliographyalmost 29 years ago
Participantsalmost 29 years ago
Introduction: Rhinitis - What It Means and Why It MattersAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?
2
Zanubrutinib Outlasting Acalabrutinib in CLL
3
FDA Clears Lerodalcibep-Liga Autoinjector, Widens LDL-C Indication
4
FITs Offer Lowest Environmental Footprint Among CRC Screening Options
5